Evidence map›Paper›PMID 29985971›Full record

ArticleBioinformatics (Oxford, England)2019

Computational analysis of kinase inhibitor selectivity using structural knowledge.

Yu-Chen Lo, Tianyun Liu, Kari M Morrissey, Satoko Kakiuchi-Kiyota, Adam R Johnson, Fabio Broccatelli, Yu Zhong, Amita Joshi, Russ B Altman

Open access · bronzeAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yu-Chen LoDepartment of Bioengineering, Stanford, CA, USA.
Tianyun LiuDepartment of Bioengineering, Stanford, CA, USA.
Kari M MorrisseyDepartment of Clinical Pharmacology, South San Francisco, CA, USA.
Satoko Kakiuchi-KiyotaDepartment of Safety Assessment, South San Francisco, CA, USA.
Adam R JohnsonBiochemical and Cellular Pharmacology, South San Francisco, CA, USA.
Fabio BroccatelliDepartment of Drug Metabolism and Pharmacokinetic, Genentech Inc., South San Francisco, CA, USA.
Yu ZhongDepartment of Safety Assessment, South San Francisco, CA, USA.
Amita JoshiDepartment of Clinical Pharmacology, South San Francisco, CA, USA.
Russ B AltmanDepartment of Bioengineering, Stanford, CA, USA.
Stanford University · US

Funding

Text Mining for High-fidelity Curation and Discovery of Gene-drug-phenotype RelationshipsR01LM005652 · NLM · STANFORD UNIVERSITY · PI ALTMAN, RUSS BIAGIO · 2000 to 2018
$6.2M
Undergraduate Summer Research Experiences Support for Combining systems biology and structural biology to find new therapeuticsR01GM102365 · NIGMS · STANFORD UNIVERSITY · PI ALTMAN, RUSS BIAGIO · 2012 to 2021
$3.0M
NIGMS NIH HHS R01 GM102365NLM NIH HHS R01 LM005652
6 · The paper itself

Abstract

Motivation: Kinases play a significant role in diverse disease signaling pathways and understanding kinase inhibitor selectivity, the tendency of drugs to bind to off-targets, remains a top priority for kinase inhibitor design and clinical safety assessment. Traditional approaches for kinase selectivity analysis using biochemical activity and binding assays are useful but can be costly and are often limited by the kinases that are available. On the other hand, current computational kinase selectivity prediction methods are computational intensive and can rarely achieve sufficient accuracy for large-scale kinome wide inhibitor selectivity profiling. Results: Here, we present a KinomeFEATURE database for kinase binding site similarity search by comparing protein microenvironments characterized using diverse physiochemical descriptors. Initial selectivity prediction of 15 known kinase inhibitors achieved an >90% accuracy and demonstrated improved performance in comparison to commonly used kinase inhibitor selectivity prediction methods. Additional kinase ATP binding site similarity assessment (120 binding sites) identified 55 kinases with significant promiscuity and revealed unexpected inhibitor cross-activities between PKR and FGFR2 kinases. Kinome-wide selectivity profiling of 11 kinase drug candidates predicted novel as well as experimentally validated off-targets and suggested structural mechanisms of kinase cross-activities. Our study demonstrated potential utilities of our approach for large-scale kinase inhibitor selectivity profiling that could contribute to kinase drug development and safety assessment. Availability and implementation: The KinomeFEATURE database and the associated scripts for performing kinase pocket similarity search can be downloaded from the Stanford SimTK website (https://simtk.org/projects/kdb). Supplementary information: Supplementary data are available at Bioinformatics online.

Indexed as

Binding SitesComputational BiologyDatabases, ProteinDrug DevelopmentProtein BindingProtein Kinase InhibitorsSignal TransductionProtein Kinase Inhibitors

Identifiers

PMID29985971
PMCPMC6330000
OpenAlexW2869298098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.